马拉维生命科学

最新新闻

• 评级变动
  UBS Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $2.5
  \u5e02\u573a\u8d44\u8baf · 2025/3/22
• 评级变动
  Deutsche Bank Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $6
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2026/2/28
• William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $4
  \u5e02\u573a\u8d44\u8baf · 2025/11/8
• 评级变动
  Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $6
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2025/8/13
• 评级变动
  Guggenheim Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• 评级变动
  Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $4.5
  \u5e02\u573a\u8d44\u8baf · 2025/12/15
• 评级变动
  A Quick Look at Today's Ratings for Maravai LifeSciences(MRVI.US), With a Forecast Between $5 to $5
  \u5e02\u573a\u8d44\u8baf · 2025/8/12
• 评级变动
  Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2025/3/25
• 评级变动
  RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $7
  \u5e02\u573a\u8d44\u8baf · 2025/4/10
• Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/5/22
• TD Cowen Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Announces Target Price $3.94
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/8/13
• Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $8
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2025/3/22

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。